Is Short Duration Chemotherapy Possible for Relapsed Germ Cell Tumours? The Phase II Trial 'GAMEC-2'

Benafif S.; Hawkesford K.; Chowdhury S.; Sarker S. J.; Wilson P.; Shamash J.

首页> 外文期刊>Clinical oncology >Is Short Duration Chemotherapy Possible for Relapsed Germ Cell Tumours? The Phase II Trial 'GAMEC-2'

【24h】

Is Short Duration Chemotherapy Possible for Relapsed Germ Cell Tumours? The Phase II Trial 'GAMEC-2'

机译：复发性生殖细胞肿瘤是否可能进行短期化疗？ II期试验“ GAMEC-2”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical oncology》 |2015年第3期|共1页
作者
Benafif S.; Hawkesford K.; Chowdhury S.; Sarker S. J.; Wilson P.; Shamash J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-18 09:34:25

相似文献

外文文献
中文文献
专利

1. Is Short Duration Chemotherapy Possible for Relapsed Germ Cell Tumours? The Phase II Trial 'GAMEC-2' [J] . Benafif S., Hawkesford K., Chowdhury S., Clinical oncology . 2015,第3期

机译：复发性生殖细胞肿瘤是否可能进行短期化疗？ II期试验“ GAMEC-2”
2. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604) [J] . Cafferty Fay H., White Jeff D., Shamash Jonathan, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第期

机译：具有强化诱导化疗的长期成果（卡铂，博尔霉素，长霉素和顺铂，依托磷脂和顺铂）和标准博来霉素，依托磷脂在预后差异细胞肿瘤中的标准博霉素：随机期II试验（ISRCTN53643604）
3. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: The multicentric TAXIF II study [J] . SelleF., WittnebelS., BironP., Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第9期

机译：多中心TAXIF II研究：一项由顺铂化疗失败的生殖细胞肿瘤（GCT）患者的造血干细胞移植（HSCT）支持的大剂量化疗（HDCT）的II期试验：
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Perturbing the epigenome: Effects of folate pathway disruptions and combination chemotherapy treatment on male germ cells. [D] . Chan, Donovan. 2012

机译：扰动表观基因组：叶酸途径破坏和联合化疗对男性生殖细胞的影响。
6. Personalised chemotherapy based on tumour marker decline in poor-prognosis germ-cell tumours: results of the GETUG 13 phase III trial [O] . Karim Fizazi Prof., Lance Pagliaro, Agnes Laplanche, -1

机译：预后不良的生殖细胞肿瘤中基于肿瘤标志物下降的个性化化疗：GETUG 13 III期试验的结果
7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial [O] . Karim Fizazi, Lance Pagliaro, Agnes Laplanche, 2014

机译：基于肿瘤标志物的个性化化疗在差的预后细胞肿瘤差（Getug 13）：3，多期，随机试验

Is Short Duration Chemotherapy Possible for Relapsed Germ Cell Tumours? The Phase II Trial 'GAMEC-2'

著录项

相似文献

相关主题

期刊订阅